Erin Kelly - Signify Health Chief Compliance Officer
| SGFYDelisted Stock | USD 30.49 0.00 0.00% |
Insider
Erin Kelly is Chief Compliance Officer of Signify Health since 2021.
| Tenure | 3 years |
| Phone | 855 984 5121 |
| Web | https://www.signifyhealth.com |
Signify Health Management Efficiency
The company has return on total asset (ROA) of 0.0254 % which means that it generated a profit of $0.0254 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1127) %, meaning that it created substantial loss on money invested by shareholders. Signify Health's management efficiency ratios could be used to measure how well Signify Health manages its routine affairs as well as how well it operates its assets and liabilities.Signify Health currently holds 333.1 M in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Signify Health has a current ratio of 5.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Signify Health's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Joseph Mirisola | Definitive Healthcare Corp | 40 | |
| MAAA FSA | Evolent Health | 51 | |
| CPA CPA | National Research Corp | 66 | |
| Peter Grua | Evolent Health | 66 | |
| Paul Horstmeier | Health Catalyst | 63 | |
| Gregory MS | National Research Corp | N/A | |
| Allison Hoffman | Phreesia | 53 | |
| Kali Beyah | Evolent Health | N/A | |
| Jim MD | Privia Health Group | N/A | |
| Kate Jensen | Definitive Healthcare Corp | 38 | |
| Richard Booth | Definitive Healthcare Corp | 55 | |
| Nicolette Sherman | Certara | 54 | |
| Dusty Lieb | Phreesia | N/A | |
| Robert JD | Definitive Healthcare Corp | 54 | |
| David Kronfeld | Definitive Healthcare Corp | N/A | |
| Patrick Nelli | Health Catalyst | N/A | |
| Mark Smith | Phreesia | 68 | |
| Scott Perricelli | Phreesia | 47 | |
| Gillian Munson | Phreesia | 50 | |
| Charles Kallenbach | Phreesia | 55 | |
| , PharmD | Certara | N/A | |
Management Performance
| Return On Equity | -0.11 | |||
| Return On Asset | 0.0254 |
Signify Health Leadership Team
Elected by the shareholders, the Signify Health's board of directors comprises two types of representatives: Signify Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Signify. The board's role is to monitor Signify Health's management team and ensure that shareholders' interests are well served. Signify Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Signify Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Senneff, President, Chief Financial Officer, Chief Administrative Officer | ||
| Stephen Wiggins, Director | ||
| Brandon Hull, Independent Director | ||
| Josh Builder, Chief Technology Officer | ||
| Jason Plagman, VP Relations | ||
| Erin Kelly, Chief Compliance Officer | ||
| Matthew Holt, Independent Chairman of the Board | ||
| Bradford Armbrester, CEO Director | ||
| Marc Rothman, Chief Medical Officer | ||
| Sam Pettijohn, Chief Growth Officer | ||
| Peter Boumenot, Chief Product Officer | ||
| Albert Notini, Independent Director | ||
| Kevin McNamara, Director | ||
| Laurence Orton, Chief Officer | ||
| Kyle Peterson, Independent Director | ||
| Taj Clayton, Independent Director | ||
| Vivian Riefberg, Independent Director | ||
| Susan Yun, Chief Officer | ||
| Adam McAnaney, General Counsel, Secretary | ||
| Laurel Douty, Executive Vice President - Clinical Operations, Episodes of Care Services | ||
| David Pierre, Chief Operating Officer | ||
| Lynn Shepherd, VP Communications | ||
| Kyle Armbrester, Chief Executive Officer, Director |
Signify Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Signify Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.11 | |||
| Return On Asset | 0.0254 | |||
| Profit Margin | (0.72) % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 6.66 B | |||
| Shares Outstanding | 179.05 M | |||
| Shares Owned By Insiders | 0.97 % | |||
| Shares Owned By Institutions | 96.18 % | |||
| Number Of Shares Shorted | 15.71 M | |||
| Price To Earning | 127.17 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Signify Stock
If you are still planning to invest in Signify Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Signify Health's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |